Cargando…

Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial

BACKGROUND: This study assessed the effects of a lactobacillus-based medication on pain intensity scores in women with endometriosis. MATERIALS AND METHODS: The present randomized pilot placebo-controlled trial was done on eligible women who were surgically and pathologically diagnosed with endometr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodaverdi, Sepideh, Mohammadbeigi, Robabeh, Khaledi, Mojdeh, Mesdaghinia, Leila, Sharifzadeh, Fatemeh, Nasiripour, Somayyeh, Gorginzadeh, Mansoureh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642422/
https://www.ncbi.nlm.nih.gov/pubmed/31310070
http://dx.doi.org/10.22074/ijfs.2019.5584
_version_ 1783436970558488576
author Khodaverdi, Sepideh
Mohammadbeigi, Robabeh
Khaledi, Mojdeh
Mesdaghinia, Leila
Sharifzadeh, Fatemeh
Nasiripour, Somayyeh
Gorginzadeh, Mansoureh
author_facet Khodaverdi, Sepideh
Mohammadbeigi, Robabeh
Khaledi, Mojdeh
Mesdaghinia, Leila
Sharifzadeh, Fatemeh
Nasiripour, Somayyeh
Gorginzadeh, Mansoureh
author_sort Khodaverdi, Sepideh
collection PubMed
description BACKGROUND: This study assessed the effects of a lactobacillus-based medication on pain intensity scores in women with endometriosis. MATERIALS AND METHODS: The present randomized pilot placebo-controlled trial was done on eligible women who were surgically and pathologically diagnosed with endometriosis. Thirty-seven participants who had not received hormonal treatment in the last three months, were enrolled and randomized into LactoFem(®)and placebo groups. Lactobacillus capsules or placebo were administrated orally once a day for 8 weeks. Patients were assessed for pain severity using Visual Analogue Scale (VAS) scores for dysmenorrhea, dyspareunia and chronic pelvic pain at baseline and after 8 and 12 weeks post-intervention. RESULTS: Mean age of participants and mean body mass index (BMI) for the LactoFem(®)and control groups were compara- ble. All patients had stage 3 and 4 of the disease based on revised American fertility society (AFS) classification of endome- triosis. Mean initial pain scores for dysmenorrhea, dyspareunia and chronic pelvic pain were 6.53 ± 2.88, 4.82 ± 3.76 and 4.19 ± 3.53, respectively in the LactoFem(®)group and 5.60 ± 2.06, 3.67 ± 2.64 and 2.88 ± 2.80, respectively for the control group; the two groups had comparable scores in this regard. There was more decrease in pain scores for both dysmenorrhea and the overall pain after 8 weeks of treatment in LactoFem(®)group compared to the control group. The scores for dysmen- orrhea were 6.53 ± 2.88 and 5.60 ± 2.06 in the LactoFem(®)and control groups, respectively, before intervention but, after 8-week treatment, these values were 3.07 ± 2.49 and 4.47 ± 2.13 (P=0.018), respectively. The changes in overall pain score in the LactoFem(®) and control group during this period were 7.33 ± 7.00 and 4.11 ± 1.68, respectively (P=0.017). CONCLUSION: This study showed some beneficial effects of lactobacillus administration on endometriosis-related pain (Registration number: IRCT20150819023684N5).
format Online
Article
Text
id pubmed-6642422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-66424222019-10-01 Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial Khodaverdi, Sepideh Mohammadbeigi, Robabeh Khaledi, Mojdeh Mesdaghinia, Leila Sharifzadeh, Fatemeh Nasiripour, Somayyeh Gorginzadeh, Mansoureh Int J Fertil Steril Original Article BACKGROUND: This study assessed the effects of a lactobacillus-based medication on pain intensity scores in women with endometriosis. MATERIALS AND METHODS: The present randomized pilot placebo-controlled trial was done on eligible women who were surgically and pathologically diagnosed with endometriosis. Thirty-seven participants who had not received hormonal treatment in the last three months, were enrolled and randomized into LactoFem(®)and placebo groups. Lactobacillus capsules or placebo were administrated orally once a day for 8 weeks. Patients were assessed for pain severity using Visual Analogue Scale (VAS) scores for dysmenorrhea, dyspareunia and chronic pelvic pain at baseline and after 8 and 12 weeks post-intervention. RESULTS: Mean age of participants and mean body mass index (BMI) for the LactoFem(®)and control groups were compara- ble. All patients had stage 3 and 4 of the disease based on revised American fertility society (AFS) classification of endome- triosis. Mean initial pain scores for dysmenorrhea, dyspareunia and chronic pelvic pain were 6.53 ± 2.88, 4.82 ± 3.76 and 4.19 ± 3.53, respectively in the LactoFem(®)group and 5.60 ± 2.06, 3.67 ± 2.64 and 2.88 ± 2.80, respectively for the control group; the two groups had comparable scores in this regard. There was more decrease in pain scores for both dysmenorrhea and the overall pain after 8 weeks of treatment in LactoFem(®)group compared to the control group. The scores for dysmen- orrhea were 6.53 ± 2.88 and 5.60 ± 2.06 in the LactoFem(®)and control groups, respectively, before intervention but, after 8-week treatment, these values were 3.07 ± 2.49 and 4.47 ± 2.13 (P=0.018), respectively. The changes in overall pain score in the LactoFem(®) and control group during this period were 7.33 ± 7.00 and 4.11 ± 1.68, respectively (P=0.017). CONCLUSION: This study showed some beneficial effects of lactobacillus administration on endometriosis-related pain (Registration number: IRCT20150819023684N5). Royan Institute 2019 2019-07-14 /pmc/articles/PMC6642422/ /pubmed/31310070 http://dx.doi.org/10.22074/ijfs.2019.5584 Text en The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited. http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Khodaverdi, Sepideh
Mohammadbeigi, Robabeh
Khaledi, Mojdeh
Mesdaghinia, Leila
Sharifzadeh, Fatemeh
Nasiripour, Somayyeh
Gorginzadeh, Mansoureh
Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title_full Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title_fullStr Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title_full_unstemmed Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title_short Beneficial Effects of Oral Lactobacillus on Pain Severity in Women Suffering from Endometriosis: A Pilot Placebo-Controlled Randomized Clinical Trial
title_sort beneficial effects of oral lactobacillus on pain severity in women suffering from endometriosis: a pilot placebo-controlled randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642422/
https://www.ncbi.nlm.nih.gov/pubmed/31310070
http://dx.doi.org/10.22074/ijfs.2019.5584
work_keys_str_mv AT khodaverdisepideh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT mohammadbeigirobabeh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT khaledimojdeh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT mesdaghinialeila beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT sharifzadehfatemeh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT nasiripoursomayyeh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial
AT gorginzadehmansoureh beneficialeffectsoforallactobacillusonpainseverityinwomensufferingfromendometriosisapilotplacebocontrolledrandomizedclinicaltrial